Brief: Minovia Therapeutics Receives FDA Fast Track Designation For Mnv-201 In Myelodysplastic Syndrome18/09/2025 14:28
Brief: Minovia Therapeutics Receives FDA Fast Track Designation For MNV-201 In Myelodysplastic Syndrome18/09/2025 12:45
Brief: Minovia Therapeutics And Launch One Acquisition Announce JV To Create Mitochondrial Therapy Company25/06/2025 13:41
Last trade - 00:00Last trade - 00:00Last trade - 00:00